Phase 1 Untreated Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

Beat AML, LLC3,000 enrolled19 locationsNCT03013998

Recruiting

Phase 1

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Myelodysplastic SyndromesRelapsed or Refractory Acute Myeloid Leukemia (AML)Untreated AML+1 more

Institut de Recherches Internationales Servier291 enrolled30 locationsNCT02074839

Recruiting

Phase 1Phase 2

Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

DLBCLUntreatedMYC Gene Rearrangement

The First Affiliated Hospital with Nanjing Medical University81 enrolled1 locationNCT04432714